dockets: DEA-2025-0654
This data as json
| id | agency_id | title | docket_type | last_modified | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEA-2025-0654 | DEA | Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026 | Rulemaking | 2026-04-20T16:02:07Z | 0b000064b909f13a | Not Assigned | To allow the Drug Enforcement Administration (DEA) to establish the 2026 aggregate production quota (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. These values need to be publicly established before allocating individual quotas to manufacturers necessary to provide for the estimated medical, scientific, research, and industrial needs of the United States, lawful export requirements, and the establishment and maintenance of reserve stocks. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-04-20T16:02:07Z", "dkAbstract": "To allow the Drug Enforcement Administration (DEA) to establish the 2026 aggregate production quota (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. These values need to be publicly established before allocating individual quotas to manufacturers necessary to provide for the estimated medical, scientific, research, and industrial needs of the United States, lawful export requirements, and the establishment and maintenance of reserve stocks.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b909f13a"} | single_get |
Links from other tables
- 1 row from docket_id in documents